Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Facebook X (Twitter) Instagram
Latest Headlines:
  • Nvidia’s Jensen Huang Courts Beijing Amid Renewed Market Access in China
  • Volcanic Eruption in Iceland Forces Evacuation of Tourists from Blue Lagoon as Lava Approaches Grindavik
  • Humanity Faces Significant Losses, Says Spokesperson
  • Gun Seller Backed by Donald Trump Jr. Launches Stock Trading
  • Lightning Strike in New Jersey Leaves 1 Dead, 13 Injured
  • Used EV Batteries Poised to Power AI Growth
  • UK Inflation Data Reveals Key Trends for June
  • Hijacked Small Plane Grounds Flights at Vancouver International Airport
  • Experts Warn of Vulnerabilities in Federal E-Verify System Following Workplace Raids
  • Trial Commences Over Alleged Facebook Privacy Violations Involving CEO and Others
  • Controversy Surrounds Franco-Israeli Singer Amir at Francofolies de Spa Festival
  • Newsom Criticizes Trump’s National Guard Move, Urges Maturity
  • Potential Consequences of Trump’s Dismissal of Fed Chair Powell
  • Prince Harry Honors Diana’s Legacy by Advocating Against Landmines in Angola
  • Tsunami Warning Lowered to Advisory Following 7.2 Magnitude Earthquake near Alaska
  • Goldman Sachs Reports Q2 2025 Earnings Results
  • Rubio Calls Israeli Strike on Damascus a ‘Misunderstanding’ Amid Peace Efforts
  • Complete Skeleton of Medieval Knight Discovered Beneath Former Ice Cream Parlor in Poland
  • James Gunn Discusses “Superman”: Release Date, Character’s Immigrant Story, and Themes of Kindness
  • Assembly Discusses Olive Grove; Tanal’s Brief Action Sparks Varank’s Controversial Remarks
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Thursday, July 17
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
FDA to Reassess Controversial Ingredient Banned in Europe

FDA to Reassess Controversial Ingredient Banned in Europe

News EditorBy News EditorMay 15, 2025 Health 6 Mins Read

The Food and Drug Administration (FDA) has announced a reevaluation of the food additive azodicarbonamide (ADA), often termed the “yoga mat” chemical, due to ongoing safety concerns. Although allowed in the United States for use in baking, this chemical is banned in Europe due to its potential carcinogenic properties when it breaks down. The FDA’s move to revisit ADA’s approval comes amid increased scrutiny of food additives and follows recent calls from advocacy groups urging a closer look at chemical safety in the food supply.

Article Subheadings
1) Overview of Azodicarbonamide
2) Concerns Raised by Advocacy Groups
3) FDA’s Response to Safety Questions
4) Broader Implications for Food Safety
5) Future Plans for Chemical Evaluation

Overview of Azodicarbonamide

Azodicarbonamide, commonly known as ADA, is primarily used in the U.S. as a food additive to whiten cereal flour and to improve the elasticity of dough in commercial bread-making. In recent years, however, its use has garnered significant attention due to the increasingly prevalent discussion on food safety and public health. This compound, while effective in achieving desired baking results, has been branded the “yoga mat” chemical because it is also found in the production of plastics and rubbers, where it serves as a foaming agent.

The FDA initially approved ADA based on studies that suggested its use within specified limits was safe for human consumption. Over time, however, as science has evolved, so too have the opinions surrounding the potential risks associated with this additive. This has raised considerable eyebrows among public health advocates and consumers alike.

Concerns Raised by Advocacy Groups

Numerous advocacy organizations have long raised alarms regarding the use of ADA in food products. The primary concern stems from the potential formation of a carcinogenic byproduct known as semicarbazide during the breakdown of ADA in certain conditions associated with food processing. This has fueled calls for a stricter regulatory approach to food additives and prompted organizations to advocate for clearer labeling and greater transparency in food manufacturing practices.

In Europe, regulators responded to these safety concerns by banning the use of ADA as a food additive entirely, citing insufficient data to support its safety. The European Food Safety Authority (EFSA) has maintained a strict stance against its use, prompting numerous discussions in the U.S. about a similar course of action. Advocacy groups argue that consumers should not be subjected to ingredients that have been categorically banned elsewhere due to health risks, igniting a dialogue about the need for rigorous testing standards.

FDA’s Response to Safety Questions

The FDA’s recent announcement regarding the reevaluation of azodicarbonamide signals a shift in the agency’s approach to food safety. Acting Deputy Commissioner Kyle Diamantas stated that the FDA has previously conducted studies assessing the amounts of semicarbazide that consumers might be exposed to through ADA. Their earlier findings indicated that while semicarbazide could lead to tumor development in laboratory mice, such risks only presented themselves at levels significantly higher than what the average person would ingest from food products.

Despite these reassurances, the establishment has faced mounting pressure to revisit its stance on various food additives. The agency’s commitment to an expanded review process reflects growing concerns raised by citizens, health experts, and advocacy organizations. During a recent Food Safety Summit conference, Diamantas emphasized the importance of a systematic evaluation of chemicals, suggesting a significant shift in how the FDA evaluates food safety moving forward.

Broader Implications for Food Safety

The reevaluation of azodicarbonamide is not isolated; it is part of a wider critical examination of food additives in the U.S. The FDA announced plans to prioritize not only ADA, but also other preservatives such as BHT and BHA, which have faced scrutiny for potential cancer risk. This has raised vital questions about the long-standing system of how food additives are approved and monitored, signalling a reevaluation of the mechanisms in place and suggesting that previous guidelines may not align with current scientific understandings.

With health authorities in various parts of the world taking a more aggressive stance on food safety, the U.S. is being prompted to re-evaluate its own standards. Increased dialogue surrounding the implications of food additives on public health is influencing consumer demand for transparency in food labeling and safety regulations.

Future Plans for Chemical Evaluation

In an effort to focus attention on the safety of existing food chemicals, FDA officials are rolling out a modernized and evidence-based prioritization scheme for reviewing chemical safety. This initiative is aimed at ensuring that all food additives undergo a thorough analysis that reflects contemporary scientific understanding and public health standards. The agency plans to open this scheme for public comment, allowing citizens to engage in the conversation around food safety and chemical evaluation.

Furthermore, the FDA intends to finalize the details of its systematic process for reviewing food chemical safety, building off the extensive feedback received from public comments. Diamantas noted that feedback from over 70,000 comments during discussions about the post-market review process framework reflects an engaged public seeking greater accountability and safety in the food supply.

No. Key Points
1 The FDA is reevaluating the safety of azodicarbonamide (ADA), a food additive linked to potential health risks.
2 ADA is banned in Europe due to concerns over its carcinogenic byproducts, prompting debates in the U.S.
3 Advocacy groups are urging the FDA to scrutinize food additives more closely for potential health risks.
4 The FDA is also reviewing other food preservatives like BHT and BHA for safety concerns.
5 A new prioritization scheme for safety review will be opened for public comment, emphasizing transparency.

Summary

The FDA’s decision to reevaluate azodicarbonamide reflects an evolving landscape regarding food safety and public health standards. Amid growing pressure from advocacy groups and an increasing awareness of food additive safety, the agency’s proactive approach could lead to significant changes in how food chemicals are reviewed and monitored moving forward. As the debate continues, consumers and experts alike are advocating for more transparency and rigorous testing of additives to ensure that food safety regulations align with contemporary scientific knowledge.

Frequently Asked Questions

Question: What is azodicarbonamide?

Azodicarbonamide (ADA) is a food additive used primarily as a dough conditioner and whitening agent in bread. It is controversial due to potential health risks linked to its breakdown products during baking.

Question: Why is azodicarbonamide banned in Europe?

ADA is banned in Europe due to concerns that it may produce a carcinogenic byproduct called semicarbazide during food processing, raising significant public health concerns.

Question: What other chemicals is the FDA reviewing?

In addition to azodicarbonamide, the FDA is also reviewing other food preservatives such as BHT and BHA, both of which have faced scrutiny regarding their potential cancer risk and safety levels.

Banned Chronic Illness Clinical Trials Controversial Disease Prevention Europe Exercise Routines FDA Fitness Health Technology Health Tips Healthcare Policy Healthcare Reform Healthy Eating Healthy Lifestyle Immunization Ingredient Medical Research Mental Health Mental Wellbeing Nutrition Patient Care Public Health Reassess Stress Management Wellness
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

Health

COVID Cases Estimated to Rise in Nearly Half of U.S. States, CDC Reports

5 Mins Read
Health

Inside the State Capitol: Law Enforcement and DNA Sharing on K-8 Campuses in California

6 Mins Read
Health

Aesthetician Offers Support for Clients Facing IVF Injections to Alleviate Infertility Stress

7 Mins Read
Health

Thousands Report Severe Pain from Essure Birth Control Device

6 Mins Read
Health

Back Surgery Saves Man from Paralysis, But He Faces $650,000 in Medical Bills

6 Mins Read
Health

Mammogram Costs Surge, Leaving Women with Unexpected Bills for Preventative Care

6 Mins Read
Mr Serdar Avatar

Serdar Imren

News Director

Facebook Twitter Instagram
Facebook X (Twitter) Instagram Pinterest
  • About Us
  • Get In Touch
  • Privacy Policy
  • Accessibility
  • Terms and Conditions
© 2025 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.